Mogamulizumab Treatment in a Hemodialysis Patient with Adult T-Cell Leukemia/Lymphoma
Main Authors: | Yoshihara, Mari, Kubota, Yasushi, Fukuda, Makoto, Kishi, Tomoya, Ikeda, Yuji, Kimura, Shinya |
---|---|
Format: | Online |
Language: | English |
Published: |
Galenos Publishing
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454062/ |
Similar Items
-
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
by: Yonekura, Kentro, et al.
Published: (2015) -
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
by: Utsunomiya, Atae
Published: (2014) -
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report
by: FUJITA, YUKIE, et al.
Published: (2016) -
Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
by: Phillips, Adrienne, et al.
Published: (2015) -
Marketing approval of mogamulizumab: A triumph for glyco-engineering
by: Beck, Alain, et al.
Published: (2012)